OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Suzanne Shelley is contibuting editor to Pharmaceutical Technology.
June 02, 2023
Makers of specialty biologics, gene therapies, and other personalized medicines are working to identify and reduce potential supply chain risks both upstream and downstream.
March 02, 2023
Stockpiling excess inventory is no longer enough to respond to supply chain volatility.
February 03, 2023
Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.
September 03, 2022
Expanded use of data analytics can help to avoid disruptions, but the possibilities cannot be realized without sufficient investment and direct human involvement.
August 03, 2022
The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.
May 03, 2022
Ongoing advances in technology and modeling techniques are helping to align all the objectives of both drug manufacturers and patients.